@article{8dcace558ae34b93a2c3a2820b229f3a,
title = "The Dilemma of Persistent Irritable Bowel Syndrome Symptoms in Patients with Quiescent Inflammatory Bowel Disease",
keywords = "Brain–gut axis, Crohn's disease, Fecal calprotectin, Inflammatory bowel disease, Irritable bowel syndrome, Microbiome, Ulcerative colitis",
author = "{P{\'e}rez de Arce}, Edith and Rodrigo Quera and Quigley, {Eamonn M.M.}",
note = "Funding Information: Conflicts of Interest: Drs E. P{\'e}rez de Arce and R. Quera report no conflicts. Dr E.M.M. Quigley serves as a consultant to 4D Pharma, Allergan, Atlantia, Biocodex, Ironwood, Novozymes, Precisionbiotics, Salix, and Vibrant and receives research funding from 4D Pharma , Biomerica , Vibrant , and Zealand Pharma . Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = sep,
doi = "10.1016/j.gtc.2021.03.008",
language = "English (US)",
volume = "50",
pages = "689--711",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders",
number = "3",
}